Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Oral Oncol. 2015 Jan 13;51(4):376–382. doi: 10.1016/j.oraloncology.2014.12.011

Figure 2.

Figure 2

Figure 2

Kaplan-Meier plots comparing p16-negative patients (blue line) and p16-positive patients (red line). A. overall survival, and B. progression-free survival. Kaplan-Meier plots comparing patients with plasma TGFβ1 levels lower than the median (blue line) and higher than the median (red line). C. overall survival, and D. progression-free survival.